Radiology, Vol 202, 247-251, Copyright © 1997 by Radiological Society of North America

ARTICLES

Nonmyelomatous monoclonal gammopathy: correlation of bone marrow MR images with laboratory findings and spontaneous clinical outcome

BC Vande Berg, L Michaux, FE Lecouvet, M Labaisse, J Malghem, J Jamart, BE Maldague, A Ferrant and JL Michaux
Department of Radiology and Medical Imaging, St Luc University Hospital, Universite Catholique de Louvain, Brussels, Belgium.

PURPOSE: To determine the frequency of abnormal bone marrow magnetic resonance (MR) images in patients with nonmyelomatous monoclonal gammopathy and to compare the outcomes in patients with normal and in those with abnormal MR studies. MATERIALS AND METHODS: In 37 patients with monoclonal gammopathy of undetermined or borderline significance (19 men, 18 women; aged 28-85 years), MR imaging findings of the vertebral, pelvic, and femoral bone marrow were analyzed and correlated with initial laboratory findings and outcome after a follow-up of 15-60 months (median, 31 months) with no treatment. RESULTS: Thirty patients had normal MR studies; none required specific therapy after a median follow-up of 30 months. Seven had either diffuse (n = 4) or focal (n = 3) bone marrow abnormalities. Four required treatment after 15, 20, 50, or 58 months; three did not require treatment after 18, 26, or 40 months. Treatment-free survival curves in patients with normal and in those with abnormal MR studies were statistically significantly different (P = .005). CONCLUSION: Bone marrow abnormalities were detected with MR imaging in seven patients (19%) with monoclonal gammopathy of undetermined or borderline significance. All patients with a normal MR investigation still had not required treatment after a median follow-up of 30 months.

This article has been cited by other articles:

				L. S. Steinbach "MRI in the Detection of Malignant Infiltration of Bone Marrow"--A Commentary Am. J. Roentgenol., June 1, 2007; 188(6): 1443 - 1445. [Full Text] [PDF]

				E. J. C. Angtuaco, A. B. T. Fassas, R. Walker, R. Sethi, and B. Barlogie Multiple Myeloma: Clinical Review and Diagnostic Imaging Radiology, April 1, 2004; 231(1): 11 - 23. [Abstract] [Full Text] [PDF]

				C. Jakob, I. Zavrski, U. Heider, M. Bollow, C.-O. Schulz, C. Fleissner, J. Eucker, R. Michael, B. Hamm, K. Possinger, et al. Serum Levels of Carboxy-terminal Telopeptide of Type-I Collagen Are Elevated in Patients with Multiple Myeloma Showing Skeletal Manifestations in Magnetic Resonance Imaging but Lacking Lytic Bone Lesions in Conventional Radiography Clin. Cancer Res., August 1, 2003; 9(8): 3047 - 3051. [Abstract] [Full Text] [PDF]

				C. Cesana, C. Klersy, L. Barbarano, A. M. Nosari, M. Crugnola, E. Pungolino, L. Gargantini, S. Granata, M. Valentini, and E. Morra Prognostic Factors for Malignant Transformation in Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma J. Clin. Oncol., March 15, 2002; 20(6): 1625 - 1634. [Abstract] [Full Text] [PDF]

				L. A. Moulopoulos and M. A. Dimopoulos Magnetic Resonance Imaging of the Bone Marrow in Hematologic Malignancies Blood, September 15, 1997; 90(6): 2127 - 2147. [Full Text] [PDF]